FDA Accepts Supplement Application for Absorica by Sun Pharma
The FDA has accepted a supplemental application for Absorica, an isotretinoin product from Sun Pharma.
Asset / Drug
Drug and asset intelligence for Absorica with 2 indexed intelligence signals across regulatory, clinical, competitive, and market developments.
No catalysts indexed for this entity yet.
No related entities indexed yet.
Newsletter
Concise strategic intelligence on regulatory, clinical, competitive, and market developments — free to subscribe.
No paywall. No spam. Unsubscribe anytime.